Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up.

Papillomavirus Research(2020)

引用 30|浏览23
暂无评分
摘要
•We report follow-up data up to 8 years after girls/boys received 9vHPV vaccine.•Durable effectiveness was observed through up to 8 years post-vaccination.•Sustained anti-HPV antibody responses were observed through at least 7 years.
更多
查看译文
关键词
Nine-valent human papillomavirus vaccine,Effectiveness,Immunogenicity,Long-term follow-up
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要